Updated:
Phreesia
Chaim Indig and Evan Roberts co-founded Phreesia in 2005, building on Indig's experience introducing Spotfire's analytics software into pharmaceutical...
Phreesia
Chaim Indig and Evan Roberts co-founded Phreesia in 2005, building on Indig's experience introducing Spotfire's analytics software into pharmaceutical marketing. The company went public on the NYSE under the ticker PHR in 2019. Phreesia's platform covers the full patient-intake cycle: online scheduling, pre-visit registration, time-of-service payments, post-visit billing, and between-visit communications. It integrates with electronic health-record systems via HL7, FHIR, and CCD standards. The company serves health systems, OB/GYN, cardiology, dermatology, and dozens of other specialties. Confirmed client types include FQHCs, children's hospitals, and multi-specialty groups (per Phreesia website, 2025). Its bidirectional integrations connect with major practice-management systems. The platform processed over 180 million patient visits in 2026 alone (per Phreesia website, 2025). The company operates across the US and maintains client-service teams in Canada and India. Adjacent operations include its Network Solutions division, which partners with life-sciences and media companies to run digital patient-engagement campaigns. Phreesia's structural differentiator is its public-company scale combined with a narrow vertical focus on patient intake and activation — a category most health-tech firms treat as a feature, not a product. Its board includes a director from HLM Venture Partners and the CFO of Take-Two Interactive, providing governance depth distinct from typical founder-run SaaS firms.
General information
Firm type
other
Year founded
2005
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Wilmington
Corporate office
Wilmington, DE, United States
Principals
Chaim Indig
Chief Executive Officer
Evan Roberts
President, Provider Solutions
Balaji Gandhi
Chief Financial Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Phreesia?
Phreesia is a publicly traded operating company, not an investment vehicle. Strategic and capital-allocation decisions are made by CEO Chaim Indig and CFO Balaji Gandhi, overseen by a board of directors that includes Lainie Goldstein (CFO of Take-Two Interactive) and Ed Saltzberg (partner at HLM Venture Partners).
How does Phreesia source proprietary deal flow?
Phreesia generates proprietary relationships through its direct sales to over 4,650 healthcare organizations and its integration network with major EHR/PM systems. Its Network Solutions division also works with life-sciences companies, providing a channel for partnership-driven innovations.
Is Phreesia structured as a single family office or does it operate more like a venture firm?
Neither. Phreesia is a publicly traded healthcare technology company (NYSE: PHR). It is not a family office or venture firm. Its capital structure is that of an operating company with public shareholders.
Does Phreesia participate in fund commitments or only direct deals?
Phreesia does not participate in fund commitments. It is an operating company, not an allocator. All capital activity relates to its own business operations, R&D, and potential M&A.
What investment stages does Phreesia typically target?
Phreesia does not make external investments as a fund. As a public company, it may pursue strategic acquisitions to expand its platform. It has not disclosed any specific M&A activity to date.
Which sectors does Phreesia explicitly avoid?
Phreesia focuses exclusively on healthcare patient intake and activation. It does not operate in non-healthcare verticals and has not disclosed any explicit avoidance list.
How is Phreesia related to its founding team and venture backers?
Phreesia was co-founded by Chaim Indig and Evan Roberts. Its founding chair is Michael Weintraub, co-founder of Ardan Equity and former CEO of Optum Analytics. Other early investors include HLM Venture Partners. The firm went public in 2019 and is now a publicly traded company.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: